Clinical Trial Update: Assess Safety and Efficacy of VAD044 in HHT Patients [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 study evaluating the safety and efficacy of VAD044 for hereditary hemorrhagic telangiectasia (HHT); the trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Hemorrhagic Telangiectasia

Drugs mentioned

• VAD044 (VAD044)

Snippet

Sponsor: Vaderis Therapeutics AG | Conditions: Hereditary Hemorrhagic Telangiectasia (HHT) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING